Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis
Public ClinicalTrials.gov record NCT00761657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects With Chronic Kidney Disease Not Requiring Dialysis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate the safety, tolerability, and pharmacodynamic effects of different oral doses of roxadustat administered 2 times a week (BIW) or 3 times a week (TIW) for up to 4 weeks to participants with chronic kidney disease (CKD) not requiring dialysis.
Study identification
- NCT ID
- NCT00761657
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2006 (Actual)
- Primary completion
- Jun 21, 2010 (Actual)
- Completion
- Jun 21, 2010 (Actual)
- Last update posted
- Nov 19, 2021
2006 – 2010
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Peoria | Arizona | 85381 | — |
| Not listed | Tempe | Arizona | 85284 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Whittier | California | 90603 | — |
| Not listed | Arvada | Colorado | 80002 | — |
| Not listed | Westminster | Colorado | 80031 | — |
| Not listed | Middlebury | Connecticut | 06762 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Panama City | Florida | 32401 | — |
| Not listed | Pembroke Pines | Florida | 33028 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Augusta | Georgia | 30901 | — |
| Not listed | Chicago | Illinois | 60616 | — |
| Not listed | Evergreen Park | Illinois | 60805 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Detroit | Michigan | 48236 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cleveland | Ohio | 44109 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Wynnewood | Pennsylvania | 19096 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Houston | Texas | 77036 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00761657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00761657 live on ClinicalTrials.gov.